comparemela.com

Latest Breaking News On - Sulfonamides - Page 1 : comparemela.com

High Output Voltage

Proton batteries are an innovative and environmentally friendly type of battery in which charge is carried by protons, which are positively charged hydrogen ions. A team of researchers has now dev .

Changsha
Hunan
China
Jiangsu
Bingan-lu
Angewandte-chemie
Hunan-university
Proton-batteries
Batteries
Protons
Sulfonamides

SELLAS Life Sciences Newly Licensed GFH009 Asset Shows Significant Anti-Leukemic Effect in Acute Myeloid Leukemia Patients Relapsed/Refractory to Venetoclax in Ongoing Phase 1 Study

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the first acute myeloid leukemia (AML) patient has enrolled in the fifth dose level (22.

China
Angelos-stergiou
Life-sciences-group-inc
Genfleet-therapeutics-shanghai-inc
Nasdaq
Memorial-sloan-kettering-cancer-center
Dose-level-cohort
Highly-selective
Dose-limiting-toxicities
First-four-dose-levels
Sciences-group
Genfleet-therapeutics

BDR Pharma inks licensing pact with Eli Lilly for Covid-19 treatment drug

Drug firm BDR Pharma on Wednesday said it has inked a licensing pact with Eli Lilly and Company for the manufacturing and distribution of Baricitinib for the treatment of COVID-19 in India. The company said it has entered into a royalty-free, limited and non-exclusive voluntary licensing agreement with Eli Lilly and Company. Baricitinib has received restricted emergency use approval, for use in combination with Remdesivir, for treatment of suspected or laboratory confirmed COVID-19 in hospitalised adults and pediatric patients two years of age or older, requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation. Eli Lilly has received the permission for the drug for restricted emergency use from Central Drugs Standard Control Organization, a division of the Ministry of Health.

India
Luca-visini
Dharmesh-shah
Eli-lilly
Ministry-of-health
Central-drugs-standard-control-organization
Chairman-dharmesh-shah
Drug-controller-general
Lilly-india-managing-director
India-subcontinent
Chemical-compounds
Organic-compounds

Eli Lilly inks pact with Natco Pharma for Covid-19 drug baricitinib

Read more about Eli Lilly inks pact with Natco Pharma for Covid-19 drug baricitinib on Business Standard. Drug firm Eli Lilly said it has signed a voluntary licensing agreement with Natco Pharma to further expedite the availability of baricitinib for Covid-19 patients in India

Hyderabad
Andhra-pradesh
India
Eli-lilly
Natco-pharma
Torrent-pharmaceuticals
Sun-pharmaceutical-industries
Cipla
Central-drugs-standard-control-organization
Direct-relief
Chemical-compounds
Organic-compounds

vimarsana © 2020. All Rights Reserved.